Andrew Berens
Stock Analyst at Leerink Partners
(0)
# 4009
Out of 5,308 analysts
221
Total ratings
47.37%
Success rate
-8.57%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CMPX Compass Therapeutics | Upgrades: Outperform | 4 6 | 1.75 | 242.86% | 3 | Apr 2, 2025 | |
ELEV Elevation Oncology | Downgrades: Market Perform | 9 1 | 0.25 | 300% | 5 | Mar 21, 2025 | |
OKUR OnKure Therapeutics | Initiates Coverage On: Outperform | 33 | 3.14 | 950.96% | 1 | Dec 5, 2024 | |
ZYME Zymeworks | Upgrades: Outperform | 10 25 | 9.99 | 150.25% | 10 | Nov 7, 2024 | |
GILD Gilead Sciences | Upgrades: Outperform | 74 96 | 105.83 | -9.29% | 1 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 60 56 | 26.25 | 113.33% | 11 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 5 3 | n/a | n/a | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 29 | 8.69 | 233.72% | 1 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Market Perform | 50 97 | 82.08 | 18.18% | 24 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 69 110 | 64.86 | 69.6% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 78 | 58.84 | 32.56% | 12 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 78 58 | n/a | n/a | 7 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 13 10 | n/a | n/a | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 48 | 39.59 | 21.24% | 5 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 30 | n/a | n/a | 11 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 162 141 | n/a | n/a | 19 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 236 300 | n/a | n/a | 11 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 20 | 4.45 | 349.44% | 4 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 37 28 | 9.6 | 191.67% | 3 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 74 70 | 6.71 | 943.22% | 5 | Nov 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 78 79 | 66.8 | 18.26% | 12 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 27 | 1.16 | 2227.59% | 7 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 4 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 30 | 0.76 | 3847.37% | 4 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 69 | n/a | n/a | 4 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 101 76 | n/a | n/a | 6 | Jun 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 23 | n/a | n/a | 5 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 36 25 | 7.79 | 220.92% | 3 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 40 | 5.33 | 650.47% | 1 | Nov 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 28 | n/a | n/a | 1 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 67 | 1.28 | 5134.38% | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | 20 | 4.06 | 392.61% | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 25 | 1.41 | 1673.05% | 1 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 12 16 | n/a | n/a | 5 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 4 3 | n/a | n/a | 6 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Overweight | 2000 | n/a | n/a | 2 | Sep 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 156 146 | n/a | n/a | 3 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 102 18 | n/a | n/a | 2 | Sep 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 75 50 | n/a | n/a | 5 | Sep 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 16 8 | 6.84 | 16.96% | 7 | Jul 14, 2017 |